The importance of components of pulmonary rehabilitation, other than exercise training, in COPD

European Respiratory Review

Volumn 22, Issue 129, 2013, Pages 405-413

  Hill, Kylie ^a,b,c   Vogiatzis, Ioannis ^d,e   Burtin, Chris ^f,g  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

^d UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^f FONTYS UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^g UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; INFLUENZA VACCINE; NICOTINE; NICOTINE GUM; PNEUMOCOCCUS VACCINE;

ARTICLE; BODY COMPOSITION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE THERAPY; DISEASE EXACERBATION; DYSPNEA; EXERCISE; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HUMAN; MENTAL HEALTH; NICOTINE REPLACEMENT THERAPY; NUTRITIONAL SUPPORT; OBESITY; OXYGEN THERAPY; PATIENT COUNSELING; PHYSICAL ACTIVITY; PULMONARY REHABILITATION; SELF CARE; SMOKING CESSATION; SOCIAL SUPPORT; TOBACCO DEPENDENCE;

PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ADVANCE CARE PLANNING; BODY COMPOSITION; COMBINED MODALITY THERAPY; EXERCISE THERAPY; HUMANS; LUNG; MENTAL HEALTH; PATIENT CARE TEAM; RECOVERY OF FUNCTION; RESPIRATORY SYSTEM AGENTS; RESPIRATORY THERAPY; RISK REDUCTION BEHAVIOR; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 84883432430     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/09059180.00002913     Document Type: Article

References (108)

1. Vestbo J, Hurd SS, Agusti AG, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary. Am J Respir Crit Care Med 2013; 187: 347-365.
2. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750.
3. Hill K, Goldstein RS, Guyatt GH, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ 2010; 182: 673-678.
4. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-1138.
5. Garcia-Aymerich J, Serra Pons I, Mannino DM, et al. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax 2011; 66: 585-590.
6. Spruit MA, Singh SJ, Garvey C, et al. An Official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation-an executive summary. Am J Respir Crit Care Med (in press).
7. Effing TW, Bourbeau J, Vercoulen J, et al. Self-management programmes for COPD: moving forward. Chron Respir Dis 2012; 9: 27-35.
8. Barlow J, Wright C, Sheasby J, et al. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns 2002; 48: 177-187.
9. Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003; 163: 585-591.
10. Connett JE, Murray RP, Buist AS, et al. Changes in smoking status affect women more than men: results of the Lung Health Study. Am J Epidemiol 2003; 157: 973-979.
11. Kanner RE, Connett JE, Williams DE, et al. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med 1999; 106: 410-416.
12. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161: 381-390.
13. Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med 2007; 101: 1305-1312.
14. Lacasse Y, Maltais F, Goldstein RS. Smoking cessation in pulmonary rehabilitation: goal or prerequisite? J Cardiopulm Rehabil 2002; 22: 148-153.
15. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-1413.
16. Young P, Dewse M, Fergusson W, et al. Respiratory rehabilitation in chronic obstructive pulmonary disease: predictors of nonadherence. Eur Respir J 1999; 13: 855-859.
17. Tonnesen P. Smoking cessation and COPD. Eur Respir Rev 2013; 22: 37-43.
18. Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane Database Syst Rev 2004; 4: CD000165.
19. Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane Database Syst Rev 2005; 3: CD001118.
20. Strassmann R, Bausch B, Spaar A, et al. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. Eur Respir J 2009; 34: 634-640.
21. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
22. Tonnesen P, Mikkelsen K, Bremann L. Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Chest 2006; 130: 334-342.
23. Paone G, Serpilli M, Girardi E, et al. The combination of a smoking cessation programme with rehabilitation increases stop-smoking rate. J Rehabil Med 2008; 40: 672-677.
24. Poole PJ, Chacko E, Wood-Baker RW, et al. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; 1: CD002733.
25. Calverley PM, Rabe KF, Goehring UM, et al. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 2009; 374: 685-694.
26. Decramer M, Celli B, Kesten S, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009; 374: 1171-1178.
27. Wilson JS, O'Neill B, Reilly J, et al. Education in pulmonary rehabilitation: the patient's perspective. Arch Phys Med Rehabil 2007; 88: 1704-1709.
28. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980; 93: 391-398.
29. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981; 1: 681-686.
30. Crisafulli E, Costi S, Luppi F, et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax 2008; 63: 487-492.
31. Wilson IB, Schoen C, Neuman P, et al. Physician-patient communication about prescription medication nonadherence: a 50-state study of America's seniors. J Gen Intern Med 2007; 22: 6-12.
32. Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009; 64: 939-943.
33. Kessler R, Stahl E, Vogelmeier C, et al. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Chest 2006; 130: 133-142.
34. Langsetmo L, Platt RW, Ernst P, et al. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med 2008; 177: 396-401.
35. Wilkinson TM, Donaldson GC, Hurst JR, et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169: 1298-1303.
36. Trappenburg JC, Monninkhof EM, Bourbeau J, et al. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax 2011; 66: 977-984.
37. Effing T, Kerstjens H, van der Valk P, et al. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax 2009; 64: 956-962.
38. Effing T. Action plans and case manager support may hasten recovery of symptoms following an acute exacerbation in patients with chronic obstructive pulmonary disease (COPD). J Physiother 2012; 58: 60.
39. Bischoff EW, Akkermans R, Bourbeau J, et al. Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial. BMJ 2012; 345: e7642.
40. Effing T, Monninkhof EM, van der Valk PD, et al. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007; 4: CD002990.
41. Puhan M, Scharplatz M, Troosters T, et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2009; 1: CD005305.
42. O'Neill S, McCarthy DS. Postural relief of dyspnoea in severe chronic airflow limitation: relationship to respiratory muscle strength. Thorax 1983; 38: 595-600.
43. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185: 435-452.
44. Breslin EH. The pattern of respiratory muscle recruitment during pursed-lip breathing. Chest 1992; 101: 75-78.
45. Bianchi R, Gigliotti F, Romagnoli I, et al. Chest wall kinematics and breathlessness during pursed-lip breathing in patients with COPD. Chest 2004; 125: 459-465.
46. Garrod R, Dallimore K, Cook J, et al. An evaluation of the acute impact of pursed lips breathing on walking distance in nonspontaneous pursed lips breathing chronic obstructive pulmonary disease patients. Chron Respir Dis 2005; 2: 67-72.
47. Solway S, Brooks D, Lau L, et al. The short-term effect of a rollator on functional exercise capacity among individuals with severe COPD. Chest 2002; 122: 56-65.
48. Probst VS, Troosters T, Coosemans I, et al. Mechanisms of improvement in exercise capacity using a rollator in patients with COPD. Chest 2004; 126: 1102-1107.
49. Cavalheri V, Camillo CA, Brunetto AF, et al. Effects of arm bracing posture on respiratory muscle strength and pulmonary function in patients with chronic obstructive pulmonary disease. Rev Port Pneumol 2010; 16: 887-891.
50. Hill K, Dolmage TE, Woon LJ, et al. Rollator use does not consistently change the metabolic cost of walking in people with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2012; 93: 1077-1080.
51. Esteban C. Role of physical activity in chronic obstructive pulmonary disease. Arch Bronconeumol 2009; 45: Suppl. 5, 7-13.
52. Pitta F, Troosters T, Probst VS, et al. Physical activity and hospitalization for exacerbation of COPD. Chest 2006; 129: 536-544.
53. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61: 772-778.
54. Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of SportsMedicine and the American Heart Association. Med Sci Sports Exerc 2007; 39: 1435-1445.
55. Zuwallack RL. How do we increase activity and participation in our patients? Semin Respir Crit Care Med 2009; 30: 708-712.
56. Barisic A, Leatherdale ST, Kreiger N. Importance of frequency, intensity, time and type (FITT) in physical activity assessment for epidemiological research. Can J Public Health 2011; 102: 174-175.
57. Murtagh EM, Boreham CA, Nevill A, et al. The effects of 60 minutes of brisk walking per week, accumulated in two different patterns, on cardiovascular risk. Prev Med 2005; 41: 92-97.
58. Donaire-Gonzalez D, Gimeno-Santos E, Balcells E, et al. Physical activity in COPD patients: patterns and bouts. Eur Respir J 2012 [In press DOI: 10.1183/09031936.00101512].
59. Pitta F, Troosters T, Probst VS, et al. Are patients with COPD more active after pulmonary rehabilitation? Chest 2008; 134: 273-280.
60. Cindy Ng LW, Mackney J, Jenkins S, et al. Does exercise training change physical activity in people with COPD? A systematic review and meta-analysis. Chron Respir Dis 2012; 9: 17-26.
61. Guell R, Casan P, Belda J, et al. Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest 2000; 117: 976-983.
62. Fernandes AC, Bezerra OM. Nutrition therapy for chronic obstructive pulmonary disease and related nutritional complications. J Bras Pneumol 2006; 32: 461-471.
63. Mallampalli A. Nutritional management of the patient with chronic obstructive pulmonary disease. Nutr Clin Pract 2004; 19: 550-556.
64. Schols AM, Soeters PB, Dingemans AM, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147: 1151-1156.
65. Pezza M, Iermano C, Tufano R. Nutritional support for the patient with chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 1994; 49: 33-39.
66. Donahoe M, Rogers RM, Wilson DO, et al. Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140: 385-391.
67. Laaban JP. Nutrition and chronic obstructive pulmonary disease. Rev Pneumol Clin 1991; 47: 235-250.
68. Prescott E, Almdal T, Mikkelsen KL, et al. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002; 20: 539-544.
69. Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008; 3: 637-658.
70. Planas M, Alvarez J, Garcia-Peris PA, et al. Nutritional support and quality of life in stable chronic obstructive pulmonary disease (COPD) patients. Clin Nutr 2005; 24: 433-441.
71. Schols AM, Soeters PB, Mostert R, et al. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 1995; 152: 1268-1274.
72. Creutzberg EC, Wouters EF, Mostert R, et al. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 2003; 19: 120-127.
73. Schols A. Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease. Proc Nutr Soc 2003; 62: 783-791.
74. Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev 2009; 18: 213-221.
75. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 728-735.
76. O'Donnell DE, O'Donnell CD, Webb KA, et al. Respiratory consequences of mild-to-moderate obesity: impact on exercise performance in health and in chronic obstructive pulmonary disease. Pulm Med 2012; 2012: 818925.
77. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856-1861.
78. Wilson DO, Rogers RM, Wright EC, et al. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139: 1435-1438.
79. Poulain M, Doucet M, Major GC, et al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ 2006; 174: 1293-1299.
80. Lessard A, Maltais F, Boulet LP. Clinical management of chronic obstructive pulmonary disease and asthma in an obese patient. Expert Opin Pharmacother 2008; 9: 83-93.
81. von Leupoldt A, Fritzsche A, Trueba AF, et al. Behavioral medicine approaches to chronic obstructive pulmonary disease. Ann Behav Med 2012; 44: 52-65.
82. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry 2000; 15: 1090-1096.
83. van Manen JG, Bindels PJ, Dekker FW, et al. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002; 57: 412-416.
84. Yohannes AM. Depression and sleep disorders predict acute exacerbations and hospitalization in patients with chronic obstructive pulmonary disease. Respirology 2012; 17: 1278.
85. Papaioannou AI, Bartziokas K, Tsikrika S, et al. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations. Eur Respir J 2013; 41: 815-823.
86. de Godoy DV, de Godoy RF. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2003; 84: 1154-1157.
87. Gelenberg AJ. A review of the current guidelines for depression treatment. J Clin Psychiatry 2010; 71: e15.
88. Gould RL, Coulson MC, Howard RJ. Efficacy of cognitive behavioral therapy for anxiety disorders in older people: a meta-analysis and meta-regression of randomized controlled trials. J Am Geriatr Soc 2012; 60: 218-229.
89. Gould RL, Coulson MC, Howard RJ. Cognitive behavioral therapy for depression in older people: a meta-analysis and meta-regression of randomized controlled trials. J Am Geriatr Soc 2012; 60: 1817-1830.
90. Cafarella PA, Effing TW, Usmani ZA, et al. Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review. Respirology 2012; 17: 627-638.
91. Coventry PA, Gellatly JL. Improving outcomes for COPD patients with mild-to-moderate anxiety and depression: a systematic review of cognitive behavioural therapy. Br J Health Psychol 2008; 13: 381-400.
92. Janssen DJ, Engelberg RA, Wouters EF, et al. Advance care planning for patients with COPD: past, present and future. Patient Educ Couns 2012; 86: 19-24.
93. Detering KM, Hancock AD, Reade MC, et al. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ 2010; 340: c1345.
94. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363: 733-742.
95. Exley C, Field D, Jones L, et al. Palliative care in the community for cancer and end-stage cardiorespiratory disease: the views of patients, lay-carers and health care professionals. Palliat Med 2005; 19: 76-83.
96. Janssen DJ, Curtis JR, Au DH, et al. Patient-clinician communication about end-of-life care for Dutch and US patients with COPD. Eur Respir J 2011; 38: 268-276.
97. Macpherson A, Walshe C, O'Donnell V, et al. The views of patients with severe chronic obstructive pulmonary disease on advance care planning: a qualitative study. Palliat Med 2013; 27: 265-272.
98. Heffner JE, Fahy B, Hilling L, et al. Attitudes regarding advance directives among patients in pulmonary rehabilitation. Am J Respir Crit Care Med 1996; 154: 1735-1740.
99. Gott M, Gardiner C, Small N, et al. Barriers to advance care planning in chronic obstructive pulmonary disease. Palliat Med 2009; 23: 642-648.
100. Burge AT, Lee A, Nicholes M, et al. Advance care planning education in pulmonary rehabilitation: a qualitative study exploring participant perspectives. Palliat Med 2013; 27: 508-515.
101. Wortz K, Cade A, Menard JR, et al. A qualitative study of patients' goals and expectations for self-management of COPD. Prim Care Respir J 2012; 21: 384-391.
102. Ellison L, Gask L, Bakerly ND, et al. Meeting the mental health needs of people with chronic obstructive pulmonary disease: a qualitative study. Chronic Illn 2012; 8: 308-320.
103. Watz H, Waschki B, Meyer T, et al. Physical activity in patients with COPD. Eur Respir J 2009; 33: 262-272.
104. Thorpe O, Johnston K, Kumar S. Barriers and enablers to physical activity participation in patients with COPD: a systematic review. J Cardiopulm Rehabil Prev 2012; 32: 359-369.
105. Hogg L, Grant A, Garrod R, et al. People with COPD perceive ongoing, structured and socially supportive exercise opportunities to be important for maintaining an active lifestyle following pulmonary rehabilitation: a qualitative study. J Physiother 2012; 58: 189-195.
106. Burton AM, Sautter JM, Tulsky JA, et al. Burden and well-being among a diverse sample of cancer, congestive heart failure, and chronic obstructive pulmonary disease caregivers. J Pain Symptom Manage 2012; 44: 410-420.
107. Jenkins S, Hill K, Cecins NM. State of the art: how to set up a pulmonary rehabilitation program. Respirology 2010; 15: 1157-1173.
108. Gloeckl R, Marinov B, Pitta F. Practical recommendations for exercise training in patients with COPD. Eur Respir Rev 2013; 22: 178-186.